Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 13, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print October 13, 2005, doi: 10.1161/01.ATV.0000190675.08857.3d
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/12/2580    most recent
01.ATV.0000190675.08857.3dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjogren, P.
Right arrow Articles by Fisher, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjogren, P.
Right arrow Articles by Fisher, R. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Metabolic Syndrome
Hazardous Substances DB
*PROSTAGLANDIN F2ALPHA

Submitted on August 25, 2005
Accepted on October 3, 2005

Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome

Per Sjogren *; Samar Basu ; Magdalena Rosell ; Angela Silveira ; Ulf de Faire ; Bengt Vessby ; Anders Hamsten ; Mai-Lis Hellenius ; and Rachel M. Fisher

From the Department of Medicine, Atherosclerosis Research Unit (P.S., A.S., A.H., R.M.F.), Karolinska Institutet; the Department of Public Health and Caring Sciences (S.B., B.V.), University of Uppsala; and the Institute of Environmental Medicine (M.R., U.d.F.) and Center for Family and Community Medicine (M.-L.H.), Karolinska Institutet, Sweden.

* To whom correspondence should be addressed. E-mail: per.sjogren{at}medks.ki.se.

Objective--The metabolic syndrome predisposes to the development of cardiovascular diseases. Oxidative stress and elevated circulating oxidized low-density lipoprotein (LDL) concentrations are related to cardiovascular disease and proposed to be features of the metabolic syndrome. F2-isoprostanes are lipid peroxidation products and considered the most reliable biomarkers of oxidative stress.

Methods and Results--Plasma oxidized LDL (oxLDL) and urinary 8-iso-prostaglandin F2{alpha} (PGF2{alpha}; the major F2-isoprostane) were analyzed in a cross-sectional study of 289 healthy men (62 to 64 years of age). Individuals completed a 7-day dietary record, and fasting plasma insulin, lipid, and lipoprotein concentrations, LDL particle size, and inflammatory markers were determined. National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) criteria were used to define the metabolic syndrome and individuals were grouped according to the number of risk factors for the metabolic syndrome (0, [n=88; 30%]; ≥1, [n=179; 62%], metabolic syndrome [n=22; 8%]). Group comparisons revealed no differences for oxLDL, 8-iso-PGF2{alpha}, or reported intake of macronutrients, whereas C-reactive protein and interleukin-6 were increased in the metabolic syndrome. LDL cholesterol strongly determined oxLDL in univariate and multivariate analysis, but no relationship to 8-iso-PGF2{alpha} was found. In turn, 8-iso-PGF2{alpha} was related to reported intake of fat, fatty acids, and dietary antioxidants.

Conclusions--There were no increases in plasma oxLDL or measures of oxidative stress (urinary 8-iso-PGF2{alpha}) in these otherwise healthy 63-year-old men with the metabolic syndrome. Furthermore, no relationship between oxLDL and 8-iso-PGF2{alpha} was found, but our results suggest a role for dietary factors in oxidative stress.


Key words: metabolic syndrome • oxLDL • isoprostanes • oxidative stress • diet




This article has been cited by other articles:


Home page
HypertensionHome page
E. R. Rietzschel, M. Langlois, M. L. De Buyzere, P. Segers, D. De Bacquer, S. Bekaert, L. Cooman, P. Van Oostveldt, P. Verdonck, G. G. De Backer, et al.
Oxidized Low-Density Lipoprotein Cholesterol Is Associated With Decreases in Cardiac Function Independent of Vascular Alterations
Hypertension, September 1, 2008; 52(3): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Maas, E. Schwedhelm, L. Kahl, H. Li, R. Benndorf, N. Luneburg, U. Forstermann, and R. H. Boger
Simultaneous Assessment of Endothelial Function, Nitric Oxide Synthase Activity, Nitric Oxide-Mediated Signaling, and Oxidative Stress in Individuals with and without Hypercholesterolemia
Clin. Chem., February 1, 2008; 54(2): 292 - 300.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. B. Meigs, M. G. Larson, C. S. Fox, J. F. Keaney Jr., R. S. Vasan, and E. J. Benjamin
Association of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes: The Framingham Offspring Study
Diabetes Care, October 1, 2007; 30(10): 2529 - 2535.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. L. Phillips and R. R. Grunstein
Obstructive sleep apnoea: time for a radical change?
Eur. Respir. J., April 1, 2006; 27(4): 671 - 673.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Holvoet, T. B. Harris, R. P. Tracy, and S. B. Kritchevsky
Oxidized LDL and the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): e31 - e31.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Sjogren, A. Hamsten, M.-L. Hellenius, and R. M. Fisher
In Response:
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): e31 - e32.
[Full Text] [PDF]